Charles River has been riding rough waters in 2024, and as the CRO’s CEO predicted, the third quarter proved no exception. | ...

Charles River Laboratories International Inc (NYSE:CRL) reported third-quarter 2024 revenue of $1.01 billion on Wednesday, a ...

Charles River Laboratories, a Wilmington, Mass., pharma services giant, is closing a Skokie office that will result in the ...

A charter company working for Charles River Laboratories was fined for improperly shipping long-tailed macaques into Canada ...

On Nov. 8, the Boston Public Health Commission released a health advisory due to a cyanobacteria bloom in Sprague Pond in Hyde Park, which falls in the Neponset River watershed. For two weeks in ...

TD Cowen raised the firm’s price target on Charles River (CRL) to $227 from $203 and keeps a Hold rating on the shares. The firm said solid 3Q results are positive indication thhe company is nearing a ...

New heat pump technology under construction will pull energy out of the river and convert it to steam for heating industrial ...

Charles River Labs (CRL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Have you evaluated the performance of Charles River Laboratories' (CRL) international operations for the quarter ending September 2024? Given the extensive global presence of this medical research ...

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2024. For the quarter, revenue was $1.01 billion, a ...